Drägerwerk Nine — Month 2026 EBIT Climbs 45% to EUR 112 Million
Drägerwerk’s preliminary third-quarter 2026 EBIT fell 15% year over year to EUR 48 million, including EUR 20.1 million in tariff refunds. Revenue rose to EUR 851 million, while order intake climbed 8% to EUR 926 million. For the first nine months of 2026, EBIT jumped 45% year over year to EUR 112 million. The group reaffirmed its 2026 outlook, including an EBIT margin of 6%—8%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2416044_de) on October 14, 2026, and is solely responsible for the information contained therein. (C)
1 million in tariff refunds. Revenue rose to EUR 851 million, while order intake climbed 8% to EUR 926 million. For the first nine months of 2026, EBIT jumped 45% year over year to EUR 112 million. The group reaffirmed its 2026 outlook, including an EBIT margin of 6%—8%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref.
ID: adhoc_2416044_de) on October 14, 2026, and is solely responsible for the information contained therein. (C)